Conformis, Inc. to Participate in Upcoming Investor Conferences
September 07 2021 - 5:00PM
Conformis, Inc. (NASDAQ: CFMS), an orthopedic medical device
company that features a range of personalized knee and hip
replacement products, announced today that Mark Augusti, Chief
Executive Officer, and Bob Howe, Chief Financial Officer, will
participate in two virtual investor conferences in September 2021.
H.C. Wainwright 23rd
Annual Global Investment Conference
- The H.C. Wainwright 23rd Annual Global Investment Conference
will take place September 13-15, 2021. A virtual presentation will
be available to watch on-demand and a webcast of the presentation
will be available at
https://journey.ct.events/view/906c3fe3-3008-421a-970a-bb8933d0dfb5.
- Conformis management will also be available for one-on-one
meetings throughout the conference. For more information about the
conference or to schedule a one-on-one meeting with management,
please contact your H.C Wainwright representative or contact
Investor Relations at ir@conformis.com or (781) 374-5598.
Oppenheimer Fall Healthcare Life Sciences & MedTech
Summit
- The Oppenheimer Fall Healthcare Life Sciences & MedTech
Summit will take place virtually September 20-23, 2021. Conformis
management will present on September 21, 2021 at 1:15 p.m. ET.
A live webcast of the presentation will be available at
https://wsw.com/webcast/oppenheimer16/cfms/2767483.
- Conformis management will also be available for one-on-one
meetings throughout the conference. For more information about the
conference or to schedule a one-on-one meeting with management,
please contact your Oppenheimer representative or contact Investor
Relations at ir@conformis.com or (781) 374-5598.
About Conformis, Inc.
Conformis is a medical technology company that uses its
proprietary iFit® Image-to-Implant® technology platform to develop,
manufacture, and sell joint replacement implants and instruments
that are individually sized and shaped, which we refer to as
personalized, individualized, or sometimes as customized, to fit
and conform to each patient’s unique anatomy. Conformis
also offers Identity Imprint™, a new line of total knee replacement
products that utilizes a proprietary algorithm to select the
implant size that most closely meets the geometric and anatomic
requirements of the patient’s knee. Conformis’ sterile,
just-in-time, Surgery-in-Box™ delivery system is available with all
of its implants and personalized, single-use instruments. Conformis
owns or exclusively in-licenses issued patents and pending patent
applications that cover personalized implants and patient-specific
instrumentation for all major joints.
For more information, visit www.conformis.com. To receive future
releases in e-mail alerts, sign up at ir.conformis.com.
Investor Contact:
ir@conformis.com
(781) 374-5598
Conformis (NASDAQ:CFMS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Conformis (NASDAQ:CFMS)
Historical Stock Chart
From Apr 2023 to Apr 2024